Format

Send to

Choose Destination
J Natl Cancer Inst. 2016 Jan 7;108(3). pii: djv413. doi: 10.1093/jnci/djv413. Print 2016 Mar.

Response.

Author information

1
Department of Radiation Oncology, University of Illinois at Chicago, Chicago, IL (MK, RRW); Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL (MK, RM, RRW); Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (UM); Department of Radiation Oncology, Yale University, New Haven, CT (ZH); Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (DJS). mkoshy@radonc.uchicago.edu.
2
Department of Radiation Oncology, University of Illinois at Chicago, Chicago, IL (MK, RRW); Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL (MK, RM, RRW); Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (UM); Department of Radiation Oncology, Yale University, New Haven, CT (ZH); Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (DJS).
PMID:
26744479
DOI:
10.1093/jnci/djv413
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center